DIVI play is done and it is history for next 3 months. There is nothing in dealing with WAG that can excite investors at this time. On the other hand, there are plenty of bad news may come from WAG. One thing is Q4 report and numbers that will be horrible and it will scare investors badly.
you don't think investors know this. 4th quarter is still playing without the express scripts contract. The estimates for the year end is $2.61 per share. P/E ratio of 12 + Walgreens could go to $42 and still maintain a respectful 16 + per share. Walgreens is greatly under valued. So my target price will be $42 to $45 per share.